New Publication: Validating a Membership Disclosure Metric for Synthetic Health Data
By Lucy Mosquera | Posted On: October 11, 2022 We have just had a paper published in JAMIA Open, entitled Validating A Membership Disclosure Metric For Synthetic Health Data, the paper validates and demonstrates, using several large datasets, how to apply a membership disclosure metric for synthetic health data, which is important for assessing the […]
Replica Analytics publishes comprehensive Cardinal Methodology for measuring and managing identity disclosure risks of datasets
OTTAWA, September 14, 2022 — A new book being published by Replica Analytics, an Aetion company, offers a complete and contemporary risk assessment methodology for accurately measuring and effectively managing the risks associated with sharing health data for secondary purposes. To innovate and improve healthcare, organizations need to leverage data, but they can face challenges sharing […]
Replica Analytics’ new estimator uses synthetic data for more reliable evaluation of re-identification risk in datasets
OTTAWA, July 19, 2022 — Replica Analytics, an Aetion company, has unveiled a novel approach to use synthetic data for a more accurate assessment of re-identification risks in datasets, to better manage privacy risks and enable greater data sharing in healthcare and other sectors. “Re-identification risk is the probability that an adversary will correctly match […]
New estimator uses synthetic data generation for more reliable evaluation of re-identification risk in datasets
By Lucy Mosquera and Abhik Das Posted on: July 5, 2022 Access to healthcare data to accelerate research remains a challenge. Even during the unprecedented Covid-19 pandemic, sharing de-identified individual-level datasets with the research community was a difficult process. One major concern among data custodians is privacy risk. However, there has been no reliable measure […]
C-Path and Replica Analytics Collaboration Aims to Accelerate Rare Disease Research
NEW YORK, OTTAWA and TUCSON, Ariz., June 29, 2022 — Critical Path Institute (C-Path) and Replica Analytics, an Aetion company, announced today a new partnership that involves leveraging synthetic data to further catalyze the generation of actionable solutions to accelerate drug development for rare diseases. Replica Analytics will help generate synthetic datasets across rare and […]